Incyte (INCY) is a publicly traded Healthcare sector company. As of August 19, 2026, INCY trades at $124.15 with a market cap of $25.03B and a P/E ratio of 46.33. INCY moved -0.02% today. Year to date, INCY is +25.01%; over the trailing twelve months it is +45.40%. Its 52-week range spans $53.56 to $132.60. Analyst consensus is buy with an average price target of $128.50. Rallies surfaces INCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest INCY news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $124.15 |
| Market Cap | $25.03B |
| P/E Ratio | 46.33 |
| EPS | $2.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $132.60 |
| 52-Week Low | $53.56 |
| Volume | 727.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.70B |
| Net Income | $597.60M |
| Gross Margin | 93.10% |
20 analysts cover INCY: 0 strong buy, 10 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $128.50.